Novacyt (France) Executives

Novacyt Management Team Effectiveness

The company has return on total asset (ROA) of (0.111) % which means that it has lost $0.111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5122) %, meaning that it generated substantial loss on money invested by shareholders. Novacyt's management efficiency ratios could be used to measure how well Novacyt manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/20/2026, Return On Tangible Assets is likely to drop to -0.78. In addition to that, Return On Capital Employed is likely to grow to -0.5. At this time, Novacyt's Total Current Liabilities is relatively stable compared to the past year. As of 02/20/2026, Non Current Liabilities Total is likely to grow to about 20 M, while Liabilities And Stockholders Equity is likely to drop slightly above 72 M. As of 02/20/2026, Common Stock Shares Outstanding is likely to grow to about 85.3 M, though Net Loss is likely to grow to (35.7 M). Novacyt maintains a total of 70.63 Million outstanding shares. Roughly 99.94 % of Novacyt outstanding shares are held by general public with 0.06 pct. owned by insiders and only 0.0 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it. Dividend Payout Ratio is expected to grow at the current pace this year, while Dividend Yield is likely to drop 0.00. As of 02/20/2026, Common Stock Shares Outstanding is likely to grow to about 85.3 M, though Net Loss is likely to grow to (35.7 M).

Novacyt Workforce Comparison

The company has Profit Margin (PM) of (1.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.65.

Novacyt Benchmark Summation

Novacyt Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Novacyt often depends on how effective the management is. Novacyt management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Novacyt management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Novacyt management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Novacyt's price analysis, check to measure Novacyt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novacyt is operating at the current time. Most of Novacyt's value examination focuses on studying past and present price action to predict the probability of Novacyt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novacyt's price. Additionally, you may evaluate how the addition of Novacyt to your portfolios can decrease your overall portfolio volatility.